cefotaxime, ceftriaxone, and imipenem). When the pneumococcus is highly resistant, glycopeptides, third-generation cephalosporins, and vancomycin are effective. As usual, the risk associated with ...

coli, particularly in ICU (intensive care units) and outpatient settings. Many antibiotics, such as cefotaxime, ceftazidime, ciprofloxacin, and levofloxacin, showed less than 20% effectiveness ...

E. coli, which is prevalent in both ICU and outpatient settings, demonstrated poor responsiveness to antibiotics like ...

Persons rely on health care providers to make diagnostic and therapeutic decisions based on the most current information. With areas of practice changing rapidly, providers are challenged to keep ...